We are live on ! Find out more
GCM

Ghisallo Capital Management Portfolio holdings

AUM $5.1B
1-Year Est. Return 39.13%
This Fund
S&P 500
This Quarter Est. Return
+15.09%
1 Year Est. Return
+39.13%
3 Year Est. Return
+121.55%
5 Year Est. Return
+121.89%
10 Year Est. Return
AUM
$5.1B
AUM Growth
+$1.47B
Cap. Flow
+$410M
Cap. Flow %
8.05%
Top 10 Hldgs %
42.59%
Holding
458
New
148
Increased
12
Reduced
51
Closed
123

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$102M
2
NVDA icon
NVIDIA
NVDA
+$95.9M
3
MSFT icon
Microsoft
MSFT
+$92.5M
4
GFS icon
GlobalFoundries
GFS
+$80.1M
5
MDLN
Medline Inc
MDLN
+$62.3M

Sector Composition

Rank Sector Weight
1 Industrials 29.61%
2 Miscellaneous 19.42%
3 Communication Services 10.49%
4 Technology 8.3%
5 Healthcare 7.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DNLI icon
176
Denali Therapeutics
DNLI
$3.86B
$2.57M 0.05%
100,000
PACH
177
Pioneer Acquisition I Corp
PACH
$293M
$2.55M 0.05%
250,000
DSAC
178
Daedalus Special Acquisition Corp
DSAC
$346M
$2.52M 0.05%
250,000
CAES
179
Cantor Equity Partners VII
CAES
$322M
$2.52M 0.05%
+250,000
New +$2.52M
ARCI
180
Archimedes Tech SPAC Partners III
ARCI
$2.5M 0.05%
250,000
GPAC
181
General Purpose Acquisition Corp
GPAC
$296M
$2.5M 0.05%
250,000
AEAQ
182
Activate Energy Acquisition Corp
AEAQ
$2.5M 0.05%
250,000
AAC.U
183
Ares Acquisition Corporation III Units
AAC.U
$2.5M 0.05%
+250,000
New +$2.51M
WLCOU
184
Wilco 63 Corporation Units
WLCOU
$200M
$2.49M 0.05%
+250,000
New +$2.48M
SORN
185
Soren Acquisition Corp
SORN
$2.48M 0.05%
250,000
CAQ
186
Cambridge Acquisition Corp
CAQ
$311M
$2.48M 0.05%
+250,000
New +$2.47M
HMH
187
HMH Holding Inc
HMH
$231M
$2.34M 0.05%
+125,000
New +$2.56M
EROK
188
EagleRock Land
EROK
$665M
$2.34M 0.05%
+110,000
New +$2.38M
AVLN
189
Avalyn Pharma
AVLN
$1.54B
$2.3M 0.05%
+70,000
New +$2.02M
CHEC
190
Chenghe Acquisition III Co
CHEC
$177M
$2.29M 0.04%
225,000
ALT icon
191
Altimmune
ALT
$603M
$2.28M 0.04%
+750,000
New +$2.24M
SHOTU
192
RMG ML Sports Holdings Unit
SHOTU
$201M
$2.25M 0.04%
+225,000
New +$2.25M
NKTR icon
193
Nektar Therapeutics
NKTR
$2.46B
$2.23M 0.04%
+32,000
New +$2.34M
LINE
194
Lineage Inc
LINE
$8.98B
$2.16M 0.04%
50,000
-50,100
-50% -$1.97M
GRDN
195
Guardian Pharmacy Services
GRDN
$2.34B
$2.09M 0.04%
50,000
-75,000
-60% -$2.9M
ALOVU
196
Aldabra 4 Liquidity Opportunity Vehicle Inc Units
ALOVU
$2.09M 0.04%
200,000
WHK
197
WhiteHawk Minerals Corp
WHK
$642M
$2.09M 0.04%
+75,000
New +$2.04M
BLUW
198
Blue Water Acquisition Corp III
BLUW
$335M
$2.06M 0.04%
200,000
NGEN
199
NervGen Pharma
NGEN
$247M
$2.06M 0.04%
+1,000,000
New +$3.1M
WENN
200
Wen Acquisition Corp
WENN
$2.06M 0.04%
200,000

Similar funds

Ghisallo Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, Ghisallo Capital Management held 458 positions worth $5.1B, up 40% from $3.63B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Ghisallo Capital Management deployed $410M of net new capital in Q2 2026, opening 148 new positions and adding to 12 existing holdings. Its largest new stake was SpaceX: 5,678,145 shares worth $970M.

By sector, the portfolio is most concentrated in Industrials at 30% of assets, up from 17% a quarter earlier, followed by Miscellaneous and Communication Services.

On the sell side, the largest reduction was Medline Inc, an estimated $62.3M trimmed.

  • Ghisallo Capital Management's largest Q2 2026 buy was SpaceX: 5,678,145 shares worth $970M.
  • Ghisallo Capital Management added most to Diamondback Energy in Q2 2026, an estimated $29.1M increase.
  • Ghisallo Capital Management's biggest Q2 2026 reduction was Medline Inc, cutting an estimated $62.3M.
  • Ghisallo Capital Management fully exited Tesla in Q2 2026, selling an estimated $102M.
  • Ghisallo Capital Management's ten largest holdings make up 43% of its $5.1B portfolio in Q2 2026.
  • Ghisallo Capital Management opened 148 new positions and closed 123 in Q2 2026.
  • Ghisallo Capital Management's portfolio value rose 40% quarter-over-quarter to $5.1B.

Based on Ghisallo Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.